Disclosures for "Treatment with Galcanezumab in Patients with Episodic Migraine: Results from the Open-Label Phase of the PERSIST Study")
-
Prof. Yu has nothing to disclose.
-
Prof. Zhou has nothing to disclose.
-
Dr. Zhuang has received personal compensation for serving as an employee of Lilly.
-
Miss Liu has nothing to disclose.
-
Ms. Qian has received personal compensation for serving as an employee of Eli Lilly.